IndraLab
Statements
BAP1 inhibits Cell Survival. 8 / 9
|
1
7
reach
"Furthermore, our results reveled that BaP1 reduced cell survival and cell motility, two desirable properties for an anticancer drug.Interestingly, when we treated RKO cells with higher doses of BaP1, 2 × IC and 4 × IC , concentrations that still have a reduced inhibitory effect in the noncancerous colon cell line NCM460, we observed well-established and correlated phenotypes."